pharma · CDK Gene Mutation · Solid Tumor, Adult · KZIA
Kazia Therapeutics
KAZIA THERAPEUTICS LTD
Kazia Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
300 Barangaroo Ave, L24, Barangaroo, New South Wales 2000, AU HQ
2016 Founded
15 Employees
Public company Type
KZIA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 300 Barangaroo Ave, L24, Barangaroo, New South Wales 2000, AU
- Founded
- 2016
- Employees
- 15
- Programs
- 13
- Drugs
- 9
- Patents
- 1
Kazia Therapeutics clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to Kazia Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Kazia Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Kazia Therapeutics.
-
Part A: Dose Escalation of Cantrixil — Phase 1
Clinical update -
PAXALISIB — Phase 2
Clinical update -
Paxalisib — Phase 2
Clinical update -
idronoxil — Phase 1
Clinical update -
GDC-0084 — Phase 1
Clinical update -
[14C]-Paxalisib Capsule — Phase 1
Clinical update -
Abemaciclib — Phase 2
Clinical update -
Paxalisib — Phase 2
Clinical update